Identification and Characterization of Genetic Variants in Hereditary Angioedema — GENOMAEH_01

Hereditary Angioedema With C1 Esterase Inhibitor Deficiency Clinical Trial

Official title:
Identification and Functional Characterization of Genetic Variants Associated With Specific Clinical Phenotypes in Hereditary Angioedema Due to C1 Inhibitor Deficiency: An Unbiased Approach

Status Not yet recruiting

Clinical Trial Summary

This project aims to analyse in an unbiased way the existence of genetic variants that contribute to explaining and predicting the differences in clinical expression between patients with HAE.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Angioedema
Hereditary Angioedema With C1 Esterase Inhibitor Deficiency

Clinical Trial Details

NCT number	NCT05833620
Study type	Observational
Source	Hospital Universitari Vall d'Hebron Research Institute
Contact	Roger Colobran, PhD
Phone	+34 93 489 30 00
Email	roger.colobran@vallhebron.cat
Status	Not yet recruiting
Phase
Start date	May 2023
Completion date	March 31, 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04618211` - Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema	Phase 2
Recruiting	`NCT06343779` - Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema	Phase 3
Recruiting	`NCT05396105` - Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema	Phase 2/Phase 3
Active, not recruiting	`NCT05047185` - Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II	Phase 2